The Fort Worth Press - FriskaAi and Dexcom Enter CGM Data Integration Agreement

USD -
AED 3.672504
AFN 65.503991
ALL 81.893517
AMD 377.703986
ANG 1.79008
AOA 917.000367
ARS 1431.463704
AUD 1.424075
AWG 1.8
AZN 1.70397
BAM 1.658906
BBD 2.014216
BDT 122.30167
BGN 1.67937
BHD 0.377004
BIF 2963.603824
BMD 1
BND 1.273484
BOB 6.910269
BRL 5.23885
BSD 1.000025
BTN 90.583306
BWP 13.239523
BYN 2.873016
BYR 19600
BZD 2.011247
CAD 1.36432
CDF 2230.000362
CHF 0.775404
CLF 0.021785
CLP 860.180396
CNY 6.93805
CNH 6.93014
COP 3691.11
CRC 495.76963
CUC 1
CUP 26.5
CVE 93.526553
CZK 20.49104
DJF 177.720393
DKK 6.318604
DOP 63.114413
DZD 129.915817
EGP 46.860804
ERN 15
ETB 155.46494
EUR 0.84612
FJD 2.209504
FKP 0.738005
GBP 0.734505
GEL 2.69504
GGP 0.738005
GHS 10.990102
GIP 0.738005
GMD 73.000355
GNF 8778.001137
GTQ 7.670255
GYD 209.225001
HKD 7.81355
HNL 26.416279
HRK 6.375104
HTG 131.004182
HUF 319.673504
IDR 16847.65
ILS 3.110675
IMP 0.738005
INR 90.60355
IQD 1310.041816
IRR 42125.000158
ISK 122.690386
JEP 0.738005
JMD 156.517978
JOD 0.70904
JPY 157.06304
KES 129.004623
KGS 87.450384
KHR 4035.7261
KMF 419.00035
KPW 900.002243
KRW 1462.730383
KWD 0.30717
KYD 0.833355
KZT 494.785725
LAK 21489.944613
LBP 89557.410282
LKR 309.387392
LRD 188.003087
LSL 16.133574
LTL 2.95274
LVL 0.60489
LYD 6.332646
MAD 9.180641
MDL 17.050476
MGA 4439.468349
MKD 52.169828
MMK 2100.00747
MNT 3580.70414
MOP 8.047618
MRU 39.542143
MUR 46.060378
MVR 15.450378
MWK 1734.055998
MXN 17.260975
MYR 3.947504
MZN 63.750377
NAD 16.133574
NGN 1367.390377
NIO 36.803155
NOK 9.658735
NPR 144.932675
NZD 1.659792
OMR 0.384466
PAB 1.000025
PEN 3.364787
PGK 4.288489
PHP 58.458038
PKR 279.633919
PLN 3.568365
PYG 6607.462446
QAR 3.645108
RON 4.308404
RSD 99.305038
RUB 77.002259
RWF 1459.579124
SAR 3.750159
SBD 8.058149
SCR 13.731545
SDG 601.503676
SEK 9.004245
SGD 1.271104
SHP 0.750259
SLE 24.450371
SLL 20969.499267
SOS 570.497977
SRD 37.818038
STD 20697.981008
STN 20.780851
SVC 8.750011
SYP 11059.574895
SZL 16.130113
THB 31.539504
TJS 9.370298
TMT 3.505
TND 2.900328
TOP 2.40776
TRY 43.592904
TTD 6.771984
TWD 31.613038
TZS 2575.000335
UAH 42.955257
UGX 3558.190624
UYU 38.652875
UZS 12280.366935
VES 377.985125
VND 25950
VUV 119.988021
WST 2.726314
XAF 556.381418
XAG 0.012857
XAU 0.000201
XCD 2.70255
XCG 1.802328
XDR 0.692248
XOF 556.381418
XPF 101.156094
YER 238.403589
ZAR 16.024104
ZMK 9001.203584
ZMW 18.62558
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • AZN

    5.8700

    193.03

    +3.04%

  • GSK

    1.0600

    60.23

    +1.76%

  • NGG

    1.1700

    88.06

    +1.33%

  • BTI

    0.8400

    62.8

    +1.34%

  • CMSC

    -0.0400

    23.51

    -0.17%

  • CMSD

    0.0600

    23.95

    +0.25%

  • BP

    0.8400

    39.01

    +2.15%

  • RIO

    2.2900

    93.41

    +2.45%

  • BCE

    -0.4900

    25.08

    -1.95%

  • JRI

    0.0900

    12.97

    +0.69%

  • RELX

    -0.7100

    29.38

    -2.42%

  • RYCEF

    0.2600

    16.88

    +1.54%

  • BCC

    1.8700

    91.03

    +2.05%

  • VOD

    0.4900

    15.11

    +3.24%

FriskaAi and Dexcom Enter CGM Data Integration Agreement
FriskaAi and Dexcom Enter CGM Data Integration Agreement

FriskaAi and Dexcom Enter CGM Data Integration Agreement

ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.

Text size:

FriskaAi is a physician-directed health and wellness platform that supports the management of diabetes and other chronic diseases by helping providers take an evidence-based approach to preventive care. The EHR-agnostic FriskaAi platform leverages advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health journey in partnership with their clinical team.

"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."

Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels wirelessly to a smart device or receiver in real-time, without the need for fingerpricks. Dexcom CGMs also offer a suite of customizable alerts that can warn of high or low glucose levels and send predictive alerts to help users spend more time in range.

The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by the powerful HIPAA-compliant FriskaAi platform. That data, along with other clinical data and studies, is continuously monitored by sophisticated AI-powered algorithms that alert the patient when action is recommended and generate actionable reports for use by the clinician at the point of care to inform care decisions.

Aggregated health data is also analyzed within the FriskaAI platform to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies.

About FriskaAi

FriskaAi is a powerful AI-enabled EHR-agnostic platform that helps physicians and other providers take an evidence-based approach to preventive care. The physician-initiated platform leverages advanced AI- and mobile technology to provide patients with personalized health insights and recommendations, empowering them to take control of their health journey in partnership with their clinical team. This aggregated health data, including information from patients' glucometers, other smart devices, and health apps, is continuously analyzed by advanced evidence-based algorithms that alert the patient when action is needed and provide clinicians with actionable reports to inform care decisions. FriskaAi also supports population health strategies by analyzing aggregated health data to identify trends and risks within a defined patient population. For more information, visit www.friska.ai.

Media Contact:
Michele Nachum
NPC Creative Services
[email protected]

SOURCE: FriskaAi



View the original press release on ACCESS Newswire

X.Silva--TFWP